AstraZeneca gets nod to launch cancer drug – Times of India
NEW DELHI: AstraZeneca Pharma India has received permission to import for sale and distribution of Durvalumab 120 mg/2.4…
NEW DELHI: AstraZeneca Pharma India has received permission to import for sale and distribution of Durvalumab 120 mg/2.4…
The Central drugs standard control organisation has announced that over 50 drugs are “not of standard quality” (NSQ)…